Net profit of Astal Laboratories rose 180.29% to Rs 7.68 crore in the quarter ended March 2026 as against Rs 2.74 crore during the previous quarter ended March 2025. Sales rose 471.15% to Rs 134.05 crore in the quarter ended March 2026 as against Rs 23.47 crore during the previous quarter ended March 2025.
For the full year,net profit rose 64.73% to Rs 14.71 crore in the year ended March 2026 as against Rs 8.93 crore during the previous year ended March 2025. Sales rose 287.87% to Rs 249.13 crore in the year ended March 2026 as against Rs 64.23 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 134.05 | 23.47 | 471 | 249.13 | 64.23 | 288 |
| OPM % | 7.60 | 17.81 | - | 8.34 | 19.88 | - |
| PBDT | 9.20 | 3.95 | 133 | 18.96 | 12.20 | 55 |
| PBT | 8.34 | 3.85 | 117 | 17.73 | 11.98 | 48 |
| NP | 7.68 | 2.74 | 180 | 14.71 | 8.93 | 65 |
Powered by Capital Market - Live News
